PLA2G4A and dry eye syndrome: In silico treatment with the drugs tested in vitro revealed distinct mechanisms of action and interactions between the cPLA2ɑ inhibition and vitamin D analogues, where the two drugs impacted different phenotypic aspects of KCs.